SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 273 filers reported holding SEATTLE GENETICS INC in Q4 2016. The put-call ratio across all filers is 2.22 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,595,000 | +52.0% | 9,384 | +3.2% | 1.34% | +20.3% |
| Q1 2020 | $1,049,000 | -2.4% | 9,090 | -3.4% | 1.12% | +13.6% |
| Q4 2019 | $1,075,000 | +8858.3% | 9,409 | +4276.3% | 0.98% | +6037.5% |
| Q4 2018 | $12,000 | -29.4% | 215 | 0.0% | 0.02% | 0.0% |
| Q3 2018 | $17,000 | -99.0% | 215 | -99.3% | 0.02% | -98.1% |
| Q2 2017 | $1,622,000 | -14.4% | 31,341 | +4.0% | 0.83% | -20.8% |
| Q1 2017 | $1,895,000 | +11.2% | 30,149 | -6.6% | 1.04% | +9.0% |
| Q4 2016 | $1,704,000 | -15.1% | 32,284 | -13.1% | 0.96% | +33.8% |
| Q3 2016 | $2,007,000 | +69.8% | 37,160 | +21.3% | 0.72% | +94.8% |
| Q3 2015 | $1,182,000 | -13.7% | 30,646 | +8.3% | 0.37% | -39.3% |
| Q2 2015 | $1,370,000 | – | 28,305 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,046,060 | $2,892,270,000 | 23.68% |
| Lagoda Investment Management, L.P. | 88,615 | $5,021,000 | 8.38% |
| Matrix Capital Management Company, LP | 3,141,852 | $178,017,000 | 5.90% |
| Opus Point Partners Management, LLC | 19,127 | $1,084,000 | 2.39% |
| EMORY UNIVERSITY | 41,539 | $2,354,000 | 1.86% |
| Capital International Sarl | 238,100 | $13,491,000 | 1.62% |
| Rhenman & Partners Asset Management AB | 242,198 | $13,723,000 | 1.57% |
| CAPITAL GUARDIAN TRUST CO | 1,341,050 | $75,984,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 42,500 | $1,890,000 | 1.17% |
| JGP Global Gestao de Recursos Ltda. | 16,524 | $936,000 | 1.14% |